ArticleHealthcare informatics research2022

Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea.

Hui Xing Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.